這項數據解讀將決定Sellas Life Sciences Group（NASDAQ:SLS）的成敗
· seekingalpha.com
SELLAS Life Sciences Group 在關鍵的 GPS 用於 AML 的第 3 期 REGAL 試驗數據公布前，是備受看好的買進標的。按此處閱讀這份 SLS 股票更新。
My buy-call on SELLAS Life Science Group, Inc. ( SLS ) here would ultimately come down to the debate surrounding what we’re seeing drive the unusually long RE...